AAAAAA

   
Results: 1-18 |
Results: 18
HIGH-DOSE CHEMOTHERAPY FOR CHRONIC LYMPHOCYTIC-LEUKEMIA - ELIGIBILITY, TIMING, AND BENEFIT
Authors: KHOURI IF KEATING MJ
Citation: If. Khouri et Mj. Keating, HIGH-DOSE CHEMOTHERAPY FOR CHRONIC LYMPHOCYTIC-LEUKEMIA - ELIGIBILITY, TIMING, AND BENEFIT, Annals of oncology, 9(2), 1998, pp. 131-132
TRANSPLANT-LITE - INDUCTION OF GRAFT-VERSUS-MALIGNANCY USING FLUDARABINE-BASED NONABLATIVE CHEMOTHERAPY AND ALLOGENEIC BLOOD PROGENITOR-CELL TRANSPLANTATION AS TREATMENT FOR LYMPHOID MALIGNANCIES
Authors: KHOURI IF KEATING M KORBLING M PRZEPIORKA D ANDERLINI P OBRIEN S GIRALT S IPPOLITI C VONWOLFF B GAJEWSKI J DONATO M CLAXTON D UENO N ANDERSSON B GEE A CHAMPLIN R
Citation: If. Khouri et al., TRANSPLANT-LITE - INDUCTION OF GRAFT-VERSUS-MALIGNANCY USING FLUDARABINE-BASED NONABLATIVE CHEMOTHERAPY AND ALLOGENEIC BLOOD PROGENITOR-CELL TRANSPLANTATION AS TREATMENT FOR LYMPHOID MALIGNANCIES, Journal of clinical oncology, 16(8), 1998, pp. 2817-2824
ALLOGENEIC PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION FOR POOR-RISK PATIENTS WITH METASTATIC BREAST-CANCER
Authors: UENO NT RONDON G MIRZA NQ GEISLER DK ANDERLINI P GIRALT SA ANDERSSON BS CLAXTON DF GAJEWSKI JL KHOURI IF KORBLING M MEHRA RC PRZEPIORKA D RAHMAN Z SAMUELS BI VANBESIEN K HORTOBAGYI GN CHAMPLIN RE
Citation: Nt. Ueno et al., ALLOGENEIC PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION FOR POOR-RISK PATIENTS WITH METASTATIC BREAST-CANCER, Journal of clinical oncology, 16(3), 1998, pp. 986-993
PRELIMINARY-REPORT OF A NEW ACTIVE REGIMEN FOR AGGRESSIVE MANTLE CELLLYMPHOMA
Authors: KHOURI IF ROMAGUERA J PALMER JL PUGH WC KORBLING M SAMUELS B GIRALT S RODRIGUEZ A PRZEPIORKA D MCLAUGHLIN P ANDERSSON B CLAXTON D MIRZA N MEHRA R HAGEMEISTER F CABANILLAS F CHAMPLIN R
Citation: If. Khouri et al., PRELIMINARY-REPORT OF A NEW ACTIVE REGIMEN FOR AGGRESSIVE MANTLE CELLLYMPHOMA, British Journal of Haematology, 102(1), 1998, pp. 240-241
BONE-MARROW TRANSPLANTATION AFTER FAILURE OF AUTOLOGOUS TRANSPLANT FOR NON-HODGKINS-LYMPHOMA
Authors: DELIMA M VANBESIEN KW GIRALT SA KHOURI IF MEHRA R ANDERSSON BS PRZEPIORKA D GAJEWSKI JL KORBLING M CHAMPLIN RE
Citation: M. Delima et al., BONE-MARROW TRANSPLANTATION AFTER FAILURE OF AUTOLOGOUS TRANSPLANT FOR NON-HODGKINS-LYMPHOMA, Bone marrow transplantation, 19(2), 1997, pp. 121-127
MANAGEMENT OF LYMPHOMA RECURRENCE AFTER ALLOGENEIC TRANSPLANTATION - THE RELEVANCE OF GRAFT-VERSUS-LYMPHOMA EFFECT
Authors: VANBESIEN KW DELIMA M GIRALT SA MOORE DF KHOURI IF RONDON G MEHRA R ANDERSSON BS DYER C CLEARY K PRZEPIORKA D GAJEWSKI JL CHAMPLIN RE
Citation: Kw. Vanbesien et al., MANAGEMENT OF LYMPHOMA RECURRENCE AFTER ALLOGENEIC TRANSPLANTATION - THE RELEVANCE OF GRAFT-VERSUS-LYMPHOMA EFFECT, Bone marrow transplantation, 19(10), 1997, pp. 977-982
ALLOGENEIC BLOOD OR MARROW TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC-LEUKEMIA - TIMING OF TRANSPLANTATION AND POTENTIAL EFFECT OF FLUDARABINEON ACUTE GRAFT-VERSUS-HOST DISEASE
Authors: KHOURI IF PRZEPIORKA D VANBESIEN K OBRIEN S PALMER JL LERNER S MEHRA RC VRIESENDORP HM ANDERSSON BS GIRALT S KORBLING M KEATING MJ CHAMPLIN RE
Citation: If. Khouri et al., ALLOGENEIC BLOOD OR MARROW TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC-LEUKEMIA - TIMING OF TRANSPLANTATION AND POTENTIAL EFFECT OF FLUDARABINEON ACUTE GRAFT-VERSUS-HOST DISEASE, British Journal of Haematology, 97(2), 1997, pp. 466-473
NEUTROPENIAS FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION - RESPONSE TO THERAPY WITH HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN
Authors: KHOURI IF IPPOLITI C GAJEWSKI J PRZEPIORKA D CHAMPLIN RE
Citation: If. Khouri et al., NEUTROPENIAS FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION - RESPONSE TO THERAPY WITH HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN, American journal of hematology, 52(4), 1996, pp. 313-315
RESULTS WITH HIGH-DOSE CHEMOTHERAPY AND UNPURGED AUTOLOGOUS STEM-CELLTRANSPLANTATION IN 73 PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA - THE MD ANDERSON EXPERIENCE
Authors: KHOURI IF KANTARJIAN HM TALPAZ M GIRALT S RIOS MO HESTER JP CHAMPLIN RE DEISSEROTH AB
Citation: If. Khouri et al., RESULTS WITH HIGH-DOSE CHEMOTHERAPY AND UNPURGED AUTOLOGOUS STEM-CELLTRANSPLANTATION IN 73 PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA - THE MD ANDERSON EXPERIENCE, Bone marrow transplantation, 17(5), 1996, pp. 775-779
ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR POOR-PROGNOSIS LYMPHOMA - RESPONSE, TOXICITY, AND SURVIVAL DEPEND ON DISEASE HISTOLOGY
Authors: VANBESIEN KW MEHRA RC GIRALT SA KANTARJIAN HM PUGH WC KHOURI IF MOON Y WILLIAMS P ANDERSSON BS PRZEPIORKA D MCCARTHY PL GAJEWSKI JL DEISSEROTH AB CABANILLAS FF CHAMPLIN R
Citation: Kw. Vanbesien et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR POOR-PROGNOSIS LYMPHOMA - RESPONSE, TOXICITY, AND SURVIVAL DEPEND ON DISEASE HISTOLOGY, The American journal of medicine, 100(3), 1996, pp. 299-307
ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR REFRACTORY AND RECURRENT LOW-GRADE LYMPHOMA - THE CASE FOR AGGRESSIVE MANAGEMENT
Authors: VANBESIEN KW KHOURI IF GIRALT SA MCCARTHY P MEHRA R ANDERSSON BS PRZEPIORKA D GAJEWSKI JL BELLARE N NATH R ROMAGUERA JE MCLAUGHLIN P KORBLING M DEISSEROTH AB CABANILLAS FF CHAMPLIN RE
Citation: Kw. Vanbesien et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR REFRACTORY AND RECURRENT LOW-GRADE LYMPHOMA - THE CASE FOR AGGRESSIVE MANAGEMENT, Journal of clinical oncology, 13(5), 1995, pp. 1096-1102
AUTOLOGOUS AND ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC-LEUKEMIA - PRELIMINARY-RESULTS
Authors: KHOURI IF KEATING MJ VRIESENDORP HM READING CL PRZEPIORKA D HUH YO ANDERSSON BS VANBESIEN KW MEHRA RC GIRALT SA IPPOLITI C MARSHALL M THOMAS MW OBRIEN S ROBERTSON LE DEISSEROTH AB CHAMPLIN RE
Citation: If. Khouri et al., AUTOLOGOUS AND ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC-LEUKEMIA - PRELIMINARY-RESULTS, Journal of clinical oncology, 12(4), 1994, pp. 748-758
REFRACTORY CHRONIC LYMPHOCYTIC-LEUKEMIA COMPLICATED BY HYPERCALCEMIA TREATED WITH ALLOGENEIC BONE-MARROW TRANSPLANTATION - CASE-REPORT AND REVIEW
Authors: SEYMOUR JF KHOURI IF CHAMPLIN RE KEATING MJ
Citation: Jf. Seymour et al., REFRACTORY CHRONIC LYMPHOCYTIC-LEUKEMIA COMPLICATED BY HYPERCALCEMIA TREATED WITH ALLOGENEIC BONE-MARROW TRANSPLANTATION - CASE-REPORT AND REVIEW, American journal of clinical oncology, 17(4), 1994, pp. 360-368
INTERLEUKIN-2 FOR PREVENTION OF GRAFT-VERSUS-HOST DISEASE AFTER HAPLOIDENTICAL MARROW TRANSPLANTATION
Authors: PRZEPIORKA D IPPOLITI C KOBERDA J CHAN KW KHOURI IF FISCHER HE HUH YO ESCUDIER SM SEONG D DAVIS M GAJEWSKI J VRIESENDORP HM CHAMPLIN RE
Citation: D. Przepiorka et al., INTERLEUKIN-2 FOR PREVENTION OF GRAFT-VERSUS-HOST DISEASE AFTER HAPLOIDENTICAL MARROW TRANSPLANTATION, Transplantation, 58(7), 1994, pp. 858-860
ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR REFRACTORY AND RECURRENT LOW-GRADE LYMPHOMA - THE CASE FOR AGGRESSIVE MANAGEMENT
Authors: VANBESIEN KW KHOURI IF GIRALT SA MCCARTHY P MEHRA R ANDERSSON BS PRZEPIORKA D GAJEWSKI JL BELLARE N NATH R ROMAGUERA JE MCLAUGHLIN PW KORBLING M DEISSEROTH AB CABANILLAS FF CHAMPLIN RE
Citation: Kw. Vanbesien et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR REFRACTORY AND RECURRENT LOW-GRADE LYMPHOMA - THE CASE FOR AGGRESSIVE MANAGEMENT, Blood, 84(10), 1994, pp. 10000205-10000205
ETOPOSIDE, CYCLOPHOSPHAMIDE (CY), TOTAL-BODY IRRADIATION (TBI), AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) FOR LOW-GRADE NON-HODGKINS-LYMPHOMA (LGL)
Authors: KHOURI IF SUKI S VANBESIEN K MCLAUGHLIN P VRIESENDORP H PRZEPIORKA D ANDERSSON B GIRALT S GAJEWSKI J MEHRA R CABANILLAS F DEISSEROTH AB CHAMPLIN RE
Citation: If. Khouri et al., ETOPOSIDE, CYCLOPHOSPHAMIDE (CY), TOTAL-BODY IRRADIATION (TBI), AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) FOR LOW-GRADE NON-HODGKINS-LYMPHOMA (LGL), Blood, 84(10), 1994, pp. 10000206-10000206
HIGH-DOSE CHEMOTHERAPY AND UNPURGED AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA (CML) - THE ANDERSON,M.D. EXPERIENCE
Authors: KHOURI IF KANTARJIAN HM TALPAZ M RIOS MB GIRALT S HESTER JP CHAMPLIN RE DEISSEROTH AB
Citation: If. Khouri et al., HIGH-DOSE CHEMOTHERAPY AND UNPURGED AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA (CML) - THE ANDERSON,M.D. EXPERIENCE, Blood, 84(10), 1994, pp. 10000537-10000537
RESPONSE TO A DOXORUBICIN HIGH-DOSE ARA-C AND CDDP-BASED REGIMEN (ASHAP) PREDICTS FOR LONG-TERM REMISSION AFTER AUTOLOGOUS MARROW TRANSPLANTATION (ABMT) IN ADVANCED HODGKINS-DISEASE (HD)
Authors: FAHMY H ANDERSSON BS SAMUELS BI SWAN F HAGEMEISTER FB GIRALT S VANBESIEN K MEHRA R PRZEPIORKA D GAJEWSKI J KHOURI IF BESA P CABANILLAS F CHAMPLIN RE
Citation: H. Fahmy et al., RESPONSE TO A DOXORUBICIN HIGH-DOSE ARA-C AND CDDP-BASED REGIMEN (ASHAP) PREDICTS FOR LONG-TERM REMISSION AFTER AUTOLOGOUS MARROW TRANSPLANTATION (ABMT) IN ADVANCED HODGKINS-DISEASE (HD), Blood, 84(10), 1994, pp. 10000708-10000708
Risultati: 1-18 |